Citius Oncology, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-10.1K | — |
| FY2022 | — | $36.3M | — |
| FY2023 | — | $25.5M | — |
| FY2024 | — | $46.1M | $112 |
| FY2025 | — | $44.9M | $3.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-10.1K | — |
| FY2022 | — | $36.3M | — |
| FY2023 | — | $25.5M | — |
| FY2024 | — | $46.1M | $112 |
| FY2025 | — | $44.9M | $3.9M |